NO20032591L - Fremgangsmåte for isolering og rensing av epotiloner - Google Patents

Fremgangsmåte for isolering og rensing av epotiloner

Info

Publication number
NO20032591L
NO20032591L NO20032591A NO20032591A NO20032591L NO 20032591 L NO20032591 L NO 20032591L NO 20032591 A NO20032591 A NO 20032591A NO 20032591 A NO20032591 A NO 20032591A NO 20032591 L NO20032591 L NO 20032591L
Authority
NO
Norway
Prior art keywords
epothilones
isolating
purifying
epothilone
desorption
Prior art date
Application number
NO20032591A
Other languages
English (en)
Other versions
NO329164B1 (no
NO20032591D0 (no
Inventor
Ernst Kuesters
Heinz Unternaehrer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20032591D0 publication Critical patent/NO20032591D0/no
Publication of NO20032591L publication Critical patent/NO20032591L/no
Publication of NO329164B1 publication Critical patent/NO329164B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Silicon Polymers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse angår en desorpsjonsprosess for epotiloner, særlig epotilon A og/eller epotilon B, fra harpikser og nye produksjons-, opparbeidings- eller rensingsprosesser eller fremstillingsfremgangsmåter for epotiloner som innbefatter nevnte desorpsjonsprosess, så vel som anvendelse av visse løsemidler for desorpsjon av epotiloner fra harpikser.
NO20032591A 2000-12-07 2003-06-06 Fremgangsmate for a desorbere, isolere og opparbeide epotiloner og anvendelse av svakt polare eller apolare losemidler for desorpsjon av epotiloner NO329164B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029895.0A GB0029895D0 (en) 2000-12-07 2000-12-07 Organic compounds
PCT/EP2001/014771 WO2002046196A1 (en) 2000-12-07 2001-12-05 Process for the isolation and purification of epothilones

Publications (3)

Publication Number Publication Date
NO20032591D0 NO20032591D0 (no) 2003-06-06
NO20032591L true NO20032591L (no) 2003-06-06
NO329164B1 NO329164B1 (no) 2010-09-06

Family

ID=9904660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032591A NO329164B1 (no) 2000-12-07 2003-06-06 Fremgangsmate for a desorbere, isolere og opparbeide epotiloner og anvendelse av svakt polare eller apolare losemidler for desorpsjon av epotiloner

Country Status (32)

Country Link
US (2) US6946561B2 (no)
EP (1) EP1345944B1 (no)
JP (1) JP4287650B2 (no)
KR (1) KR100894990B1 (no)
CN (1) CN1263761C (no)
AR (1) AR031902A1 (no)
AT (1) ATE292132T1 (no)
AU (2) AU2493602A (no)
BR (1) BR0115991A (no)
CA (1) CA2433414C (no)
CZ (1) CZ301664B6 (no)
DE (1) DE60109814T2 (no)
DK (1) DK1345944T3 (no)
EC (1) ECSP034641A (no)
ES (1) ES2239687T3 (no)
GB (1) GB0029895D0 (no)
HK (1) HK1059618A1 (no)
HU (1) HU224910B1 (no)
IL (2) IL156088A0 (no)
MX (1) MXPA03005097A (no)
MY (1) MY128409A (no)
NO (1) NO329164B1 (no)
NZ (1) NZ526197A (no)
PE (1) PE20020568A1 (no)
PL (1) PL209406B1 (no)
PT (1) PT1345944E (no)
RU (1) RU2285007C2 (no)
SI (1) SI1345944T1 (no)
SK (1) SK287356B6 (no)
TW (1) TWI286137B (no)
WO (1) WO2002046196A1 (no)
ZA (1) ZA200304296B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867305B2 (en) 1996-12-03 2005-03-15 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
JP4579351B2 (ja) * 1996-12-03 2010-11-10 スローン−ケッタリング インスティトュート フォア キャンサー リサーチ エポチロンの合成とその中間体及びその類似物並びにその使用
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
GB0029895D0 (en) * 2000-12-07 2001-01-24 Novartis Ag Organic compounds
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
DK1767535T3 (da) * 2002-08-23 2010-04-12 Sloan Kettering Inst Cancer Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
MXPA05003006A (es) * 2002-09-23 2005-06-22 Squibb Bristol Myers Co Metodos para la preparacion, aislamiento y purificacion de epotilona b y estructuras cristalinas de rayos x y de epotilona b.
FR2846520B1 (fr) 2002-11-06 2006-09-29 Roquette Freres Utilisation de maltodextrines branchees comme liants de granulation
KR100681811B1 (ko) * 2005-03-15 2007-02-12 성균관대학교산학협력단 생물학적 대사부산물의 효율적인 제거를 통한 유용 이차대사산물의 제조방법
NZ574194A (en) 2006-08-16 2011-12-22 Novartis Ag Crystal form of epothilone b and use in pharmaceutical compositions
US8906947B2 (en) 2008-02-01 2014-12-09 Zhejiang Hisun Pharmaceutical Co., Ltd. Method for the separation and purification of epothilones
CN105797168A (zh) 2010-05-18 2016-07-27 天蓝制药公司 用于治疗自身免疫性疾病或其它疾病的组合物和方法
KR101372563B1 (ko) * 2011-12-26 2014-03-14 주식회사 삼양바이오팜 에포틸론 함유물질로부터 에포틸론 ａ와 ｂ의 추출 및 정제 방법
CN110964029B (zh) * 2019-12-19 2020-11-03 鲁南制药集团股份有限公司 一种埃博霉素b发酵液的预处理方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
EP1367057B1 (de) * 1996-11-18 2008-09-17 Gesellschaft für biotechnologische Forschung mbH (GBF) Epothilone E und F
ATE224882T1 (de) * 1997-07-16 2002-10-15 Schering Ag Thiazolderivate, verfahren zur herstellung und verwendung
US6365749B1 (en) * 1997-12-04 2002-04-02 Bristol-Myers Squibb Company Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
DE19826988A1 (de) * 1998-06-18 1999-12-23 Biotechnolog Forschung Gmbh Epothilon-Nebenkomponenten
EP1652926B1 (en) * 2000-04-28 2009-09-30 Kosan Biosciences, Inc. Crystalline epothilone d
GB0029895D0 (en) * 2000-12-07 2001-01-24 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
ZA200304296B (en) 2004-04-23
GB0029895D0 (en) 2001-01-24
PE20020568A1 (es) 2002-07-22
PT1345944E (pt) 2005-08-31
WO2002046196A1 (en) 2002-06-13
JP4287650B2 (ja) 2009-07-01
MY128409A (en) 2007-01-31
MXPA03005097A (es) 2003-09-05
JP2004521879A (ja) 2004-07-22
CZ20031565A3 (cs) 2003-10-15
HK1059618A1 (en) 2004-07-09
AU2002224936B2 (en) 2005-09-22
PL361884A1 (en) 2004-10-04
HUP0302579A3 (en) 2004-10-28
IL156088A (en) 2008-08-07
SK6892003A3 (en) 2004-01-08
KR20030053535A (ko) 2003-06-28
NZ526197A (en) 2005-01-28
AU2493602A (en) 2002-06-18
NO329164B1 (no) 2010-09-06
CN1479741A (zh) 2004-03-03
US20040054188A1 (en) 2004-03-18
NO20032591D0 (no) 2003-06-06
CZ301664B6 (cs) 2010-05-19
US20050288514A1 (en) 2005-12-29
EP1345944B1 (en) 2005-03-30
KR100894990B1 (ko) 2009-04-24
ES2239687T3 (es) 2005-10-01
SK287356B6 (sk) 2010-08-09
DE60109814D1 (de) 2005-05-04
EP1345944A1 (en) 2003-09-24
AR031902A1 (es) 2003-10-08
DE60109814T2 (de) 2006-02-16
RU2285007C2 (ru) 2006-10-10
CN1263761C (zh) 2006-07-12
US7569698B2 (en) 2009-08-04
IL156088A0 (en) 2003-12-23
BR0115991A (pt) 2004-01-13
CA2433414C (en) 2011-01-25
ECSP034641A (es) 2003-07-25
CA2433414A1 (en) 2002-06-13
PL209406B1 (pl) 2011-08-31
ATE292132T1 (de) 2005-04-15
HU224910B1 (en) 2006-04-28
US6946561B2 (en) 2005-09-20
SI1345944T1 (sl) 2005-12-31
DK1345944T3 (da) 2005-05-30
HUP0302579A2 (hu) 2003-11-28
TWI286137B (en) 2007-09-01

Similar Documents

Publication Publication Date Title
NO20032591L (no) Fremgangsmåte for isolering og rensing av epotiloner
WO2007140989A3 (en) Process for the manufacture of 2-butyl-3- (4-methoxybenzoyl) -5-nitrobenzofurane and use thereof in the production of of medicaments
NO20050929L (no) Fremgangsmater for fremstilling, isolering og rensing av epotilon B og rontgen krystallstrukturer av eptilon B
EA200800358A1 (ru) Способ извлечения диоксида углерода высокой степени чистоты из газообразных источников, содержащих соединения азота
PL1896389T3 (pl) Sposób otrzymywania dronabinolu z kannabidiolu z zastosowaniem sita molekularnego
TNSN07143A1 (en) Aqueous, radiation-hardenable resins, method for the production thereof, and use of the same
UA90188C2 (ru) Способ выделения кислот из реакционных смесей и способ получения триамидов тиофосфорной кислоты
WO2007011951A3 (en) Purification of paricalcitol
BRPI0312521B8 (pt) método para a separação de fibrinogênio de plasminogênio
WO2008108429A1 (ja) ２－メチル－３－（３，４－メチレンジオキシフェニル）プロパナールの品質保持方法、及びその製造方法
WO2006063667A3 (de) Verfahren zur kontinuierlichen herstellung von amino-gruppen tragenden silicium-verbindungen
WO2003089420A3 (en) Recovery and purification of anhydro sugar alcohols from a vapor stream
WO2004113315A3 (en) Production of 5-methyl-dihydro-furan-2-one from levulinic acid in supercritical media
DE602005026099D1 (de) Transformierte saccharomyces cerevisiae sowie verfahren zur massenproduktion des proteins lk8 damit
AU2003258667A1 (en) Method for the production by fermentation of sulphur-containing fine chemicals (metf)
WO2004024933A3 (de) Verfahren zur fermentativen herstellung schwefelhaltiger feinchemikalien (mety)
DE602006006840D1 (de) Verfahren zur aufreinigung des alpha-1-proteinase-inhibitors (a1pi)
NO20052329L (no) Fremgangsmate for rensingen av 1,4-butandiol-mononitrat
EA200500329A1 (ru) Способ получения глюкозы из целлюлозосодержащего сырья, преимущественно отходов пивного производства
ATE406205T1 (de) Verfahren zum verwenden eines umkehrstromreaktors
ITRM20010477A1 (it) Procedimento per la produzione o rigenerazione di un pneumatico, comepure dispositivo di riporto di battistrada.
ATE402157T1 (de) Verfahren zur herstellung von mycophenolatmofetil
ATE358660T1 (de) Verfahren zur hydrierung von aceton
SE0402178D0 (sv) Anordning och metod relaterande processindustri
ATE501145T1 (de) Narkotinreinigungsverfahren

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees